Plus Therapeutics (PSTV) EBIT Margin (QoQ) (2011 - 2026)
Plus Therapeutics (PSTV) EBIT Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Plus Therapeutics |
37.48 Mn |
22.37 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-27,247.00 |
| Dec 31, 2025 |
-9,921.00 |
| Sep 30, 2025 |
-21,018.00 |
| Jun 30, 2025 |
22,325.00 |
| Mar 31, 2025 |
-5,770.00 |
| Dec 31, 2024 |
-1,528.00 |
| Sep 30, 2024 |
2,813.00 |
| Jun 30, 2024 |
-9,233.00 |
| Mar 31, 2024 |
9,711.00 |
| Dec 31, 2023 |
-21,994.00 |
| Sep 30, 2023 |
648.00 |
| Jun 30, 2023 |
86,403.00 |
| Mar 31, 2023 |
344,300.00 |
| Dec 31, 2022 |
259,068.00 |
| Mar 31, 2019 |
-17,379.00 |
| Dec 31, 2018 |
12,524.00 |
| Sep 30, 2018 |
2,014.00 |
| Jun 30, 2018 |
31,565.00 |
| Mar 31, 2018 |
-4,701.00 |
| Dec 31, 2017 |
38,164.00 |
